Compare OTLK & CSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.